These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34110812)

  • 1. Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
    Deng Y; Deng S; Ho YH; Gardner SM; Huang Z; Marmorstein R; Huang R
    J Med Chem; 2021 Jun; 64(12):8263-8271. PubMed ID: 34110812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis for histone H4- and H2A-specific amino-terminal acetylation by NatD.
    Magin RS; Liszczak GP; Marmorstein R
    Structure; 2015 Feb; 23(2):332-41. PubMed ID: 25619998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of A Continuous Fluorescence-Based Assay for
    Ho YH; Chen L; Huang R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435607
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Oncohistone Mutations and PTM Crosstalk on the N-Terminal Acetylation Activities of NatD.
    Ho YH; Huang R
    ACS Chem Biol; 2023 Apr; 18(4):693-700. PubMed ID: 35044762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Play between Human N-α-acetyltransferase D and H4-mutant Histones: Molecular Dynamics Study.
    Rathod SB; Srivastava KR
    Curr Protein Pept Sci; 2023; 24(4):339-354. PubMed ID: 36924088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
    Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
    Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human N-alpha-acetyltransferase 40 (hNaa40p/hNatD) is conserved from yeast and N-terminally acetylates histones H2A and H4.
    Hole K; Van Damme P; Dalva M; Aksnes H; Glomnes N; Varhaug JE; Lillehaug JR; Gevaert K; Arnesen T
    PLoS One; 2011; 6(9):e24713. PubMed ID: 21935442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.
    Ju J; Chen A; Deng Y; Liu M; Wang Y; Wang Y; Nie M; Wang C; Ding H; Yao B; Gui T; Li X; Xu Z; Ma C; Song Y; Kvansakul M; Zen K; Zhang CY; Luo C; Fang M; Huang DCS; Allis CD; Tan R; Zeng CK; Wei J; Zhao Q
    Nat Commun; 2017 Oct; 8(1):928. PubMed ID: 29030587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60.
    Wu J; Xie N; Wu Z; Zhang Y; Zheng YG
    Bioorg Med Chem; 2009 Feb; 17(3):1381-6. PubMed ID: 19114310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisubstrate inhibitors to target histone acetyltransferase 1.
    Ngo L; Brown T; Zheng YG
    Chem Biol Drug Des; 2019 May; 93(5):865-873. PubMed ID: 30637990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathway.
    Pavlou D; Kirmizis A
    Apoptosis; 2016 Mar; 21(3):298-311. PubMed ID: 26666750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition.
    Wolf E; De Angelis J; Khalil EM; Cole PA; Burley SK
    J Mol Biol; 2002 Mar; 317(2):215-24. PubMed ID: 11902838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bisubstrate analog inhibitors of serotonin N-acetyltransferase: the importance of being neutral.
    Zheng W; Cole PA
    Bioorg Chem; 2003 Oct; 31(5):398-411. PubMed ID: 12941292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.
    Jonckheere V; Van Damme P
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
    van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis.
    Charidemou E; Tsiarli MA; Theophanous A; Yilmaz V; Pitsouli C; Strati K; Griffin JL; Kirmizis A
    BMC Biol; 2022 Jan; 20(1):22. PubMed ID: 35057804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor.
    Poux AN; Cebrat M; Kim CM; Cole PA; Marmorstein R
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14065-70. PubMed ID: 12391296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
    Karukurichi KR; Cole PA
    Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.
    Demetriadou C; Pavlou D; Mpekris F; Achilleos C; Stylianopoulos T; Zaravinos A; Papageorgis P; Kirmizis A
    Cell Death Dis; 2019 Mar; 10(3):236. PubMed ID: 30858358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
    Sagar V; Zheng W; Thompson PR; Cole PA
    Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.